Ben Lawrence

Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer

Belinda Lee, Lara Lipton, Joshua D. Cohen et al. · Annals of Oncology · 2019 · 213 citations · Full text

Medicine, Oncology, Surgery +17

Limitations in small intestinal neuroendocrine tumor therapy by mTor kinase inhibition reflect growth factor–mediated PI3K feedback loop activation via ERK1/2 and AKT

Bernhard Svejda, Mark Kidd, Alexander D. Kazberouk et al. · Cancer · 2011 · 80 citations · Full text

Medicine, Oncology, Pharmacology +16

A mechanistic role for the chromatin modulator, NAP1L1, in pancreatic neuroendocrine neoplasm proliferation and metastases

Simon Schimmack, Andrew Taylor, Ben Lawrence et al. · Epigenetics & Chromatin · 2014 · 71 citations · Full text

Medicine, Cancer Biology, Molecular Genetics +17

Recurrent loss of heterozygosity correlates with clinical outcome in pancreatic neuroendocrine cancer

Ben Lawrence, Cherie Blenkiron, Kate Parker et al. · npj Genomic Medicine · 2018 · 62 citations · Full text

Medicine, Genetics, Oncology +17

Serotonin and the 5‐<scp>HT</scp>7 receptor: The link between hepatocytes, <scp>IGF</scp>‐1 and small intestinal neuroendocrine tumors

Bernhard Svejda, Mark Kidd, Andrew T. Timberlake et al. · Cancer Science · 2013 · 44 citations · Full text

Medicine, Molecular Biology, Oncology +17